Delivery Order SPE2DX22D0010-SPE2D826FCB11
- Not listed
- The U.S. Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl Transdermal Patch 37.5 micrograms, with a ceiling value of $1,934.74. The contract, awarded on July 25, 2025, employs firm fixed-price pricing and is scheduled for completion by July 28, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Fentanyl Transdermal Patch 37.5 micrograms with a ceiling value of $7,063.91. This firm fixed price delivery order, with an ultimate completion date of December 17, 2025, represents a non-competitive procurement executed under the company's existing indefinite delivery contract vehicle. The award was made to AmerisourceBergen's corporate office...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $8,089.77 for fentanyl transdermal patches (37.5 mcg) under a firm fixed-price contract with the Defense Logistics Agency Medical Supply Chain. The award, issued on September 12, 2025, carries an ultimate completion date of September 15, 2025, and represents a non-competitive, non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,097.04 to AmerisourceBergen Drug Corp for the supply of Fentanyl 75 mcg/hr patches (quantity of 5 units). The contract is categorized as a firm fixed-price delivery order with an ultimate completion date of December 15, 2025, and carries no set-aside designation. This award was issued competitively and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Fentanyl Transdermal Patch 37.5 mcg with a ceiling value of $8,748.75. This firm fixed-price delivery order, with an ultimate completion date of August 28, 2025, will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through the federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 mcg/hr patches in quantities of five units, valued at $1,118.52. This competitive award, made on October 21, 2025, with an ultimate completion date of October 22, 2025, utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger contract vehicle with DLA. The contractor, headquartered in Conshohocken, Pennsylvania, will perform at its...
- The Defense Logistics Agency awarded a delivery order valued at $7,037.29 to AmerisourceBergen Drug Corp for the supply of Fentanyl 100 mcg/hr patches (5 count) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December...
- The Defense Logistics Agency (DLA) awarded a $1,846.14 delivery order to AmerisourceBergen Drug Corp for Fentanyl 37.5 micrograms per hour transdermal patches (5-count units) on December 4, 2025, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the...
- The Defense Logistics Agency awarded a delivery order valued at $1,312.50 to AmerisourceBergen Drug Corp for the supply of Fentanyl 37.5 micrograms per hour patches (five-unit quantity). This competitively awarded, firm fixed-price delivery order was issued on October 15, 2025, with an ultimate completion date of October 16, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,804.87 firm-fixed-price delivery order is for the supply of 4565884446 Fentanyl Transdermal Patches at 37.5 mcg. The contract has an ultimate completion date of September 23, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger indefinite delivery contract valued up to $999,999,999 with the DLA...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FCB11Delivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $4,842.34 for Fentanyl Transdermal Patch 87.5mcg, with an ultimate completion date of December 30, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that supports military healthcare systems globally. AmerisourceBergen's federal contract portfolio demonstrates extensive capability in supplying controlled substances, specialty pharmaceuticals, and medical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The company's consistent performance on competitive pharmaceutical procurement awards positions it as a critical vendor within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 12/28/25 |